PepGen Inc.

As of April 21, 2025, the technical trend is mildly bearish, indicated by a mix of bearish moving averages and Bollinger Bands, while the weekly MACD shows mild bullishness, suggesting weak bullish momentum compared to the S&P 500.

PepGen Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $30 million and a market cap of $46.14 million. Key metrics include a P/E ratio of NA, a dividend yield of 0.00%, and a return on equity of -111.28%.

As of Jun 18, PepGen Inc. has a market capitalization of 46.14 million, with net sales of 0.00 million and a net profit of -102.16 million over the last four quarters. The company has shareholder's funds of 118.62 million and total assets of 150.88 million as of Dec 24.